{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "17772-131",
      "generic_name": "viloxazine hydrochloride",
      "labeler_name": "Supernus Pharmaceuticals, Inc",
      "brand_name": "QELBREE",
      "active_ingredients": [
        {
          "name": "VILOXAZINE HYDROCHLORIDE",
          "strength": "100 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "17772-131-01",
          "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-131-01)",
          "marketing_start_date": "20210402",
          "sample": false
        },
        {
          "package_ndc": "17772-131-07",
          "description": "7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-131-07)",
          "marketing_start_date": "20210402",
          "sample": true
        },
        {
          "package_ndc": "17772-131-30",
          "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-131-30)",
          "marketing_start_date": "20210402",
          "sample": false
        },
        {
          "package_ndc": "17772-131-60",
          "description": "60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-131-60)",
          "marketing_start_date": "20210402",
          "sample": false
        },
        {
          "package_ndc": "17772-131-90",
          "description": "90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-131-90)",
          "marketing_start_date": "20210402",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "NDA",
      "dosage_form": "CAPSULE, EXTENDED RELEASE",
      "spl_id": "5b89031c-41a3-d7e0-e063-6294a90af6fb",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20210402",
      "product_id": "17772-131_5b89031c-41a3-d7e0-e063-6294a90af6fb",
      "application_number": "NDA211964",
      "brand_name_base": "QELBREE",
      "pharm_class": [
        "Cytochrome P450 1A2 Inhibitors [MoA]",
        "Cytochrome P450 2B6 Inhibitors [MoA]",
        "Cytochrome P450 2D6 Inhibitors [MoA]",
        "Cytochrome P450 3A4 Inhibitors [MoA]",
        "Norepinephrine Reuptake Inhibitor [EPC]",
        "Norepinephrine Uptake Inhibitors [MoA]"
      ]
    }
  ]
}